Correlation Between Shanghai Pharmaceuticals and AmerisourceBergen
Can any of the company-specific risk be diversified away by investing in both Shanghai Pharmaceuticals and AmerisourceBergen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Pharmaceuticals and AmerisourceBergen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shanghai Pharmaceuticals Holding and AmerisourceBergen, you can compare the effects of market volatilities on Shanghai Pharmaceuticals and AmerisourceBergen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Pharmaceuticals with a short position of AmerisourceBergen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Pharmaceuticals and AmerisourceBergen.
Diversification Opportunities for Shanghai Pharmaceuticals and AmerisourceBergen
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Shanghai and AmerisourceBergen is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Pharmaceuticals Holdi and AmerisourceBergen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AmerisourceBergen and Shanghai Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Pharmaceuticals Holding are associated (or correlated) with AmerisourceBergen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AmerisourceBergen has no effect on the direction of Shanghai Pharmaceuticals i.e., Shanghai Pharmaceuticals and AmerisourceBergen go up and down completely randomly.
Pair Corralation between Shanghai Pharmaceuticals and AmerisourceBergen
Assuming the 90 days horizon Shanghai Pharmaceuticals Holding is expected to generate 3.34 times more return on investment than AmerisourceBergen. However, Shanghai Pharmaceuticals is 3.34 times more volatile than AmerisourceBergen. It trades about 0.07 of its potential returns per unit of risk. AmerisourceBergen is currently generating about 0.09 per unit of risk. If you would invest 69.00 in Shanghai Pharmaceuticals Holding on August 31, 2024 and sell it today you would earn a total of 84.00 from holding Shanghai Pharmaceuticals Holding or generate 121.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Shanghai Pharmaceuticals Holdi vs. AmerisourceBergen
Performance |
| Timeline |
| Shanghai Pharmaceuticals |
| AmerisourceBergen |
Shanghai Pharmaceuticals and AmerisourceBergen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Shanghai Pharmaceuticals and AmerisourceBergen
The main advantage of trading using opposite Shanghai Pharmaceuticals and AmerisourceBergen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Pharmaceuticals position performs unexpectedly, AmerisourceBergen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AmerisourceBergen will offset losses from the drop in AmerisourceBergen's long position.| Shanghai Pharmaceuticals vs. Cardinal Health | Shanghai Pharmaceuticals vs. Henry Schein | Shanghai Pharmaceuticals vs. Sinopharm Group Co | Shanghai Pharmaceuticals vs. SINOPHARM GROUP 15ON |
| AmerisourceBergen vs. Cardinal Health | AmerisourceBergen vs. Henry Schein | AmerisourceBergen vs. Shanghai Pharmaceuticals Holding | AmerisourceBergen vs. Sinopharm Group Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets |